Featured Research

from universities, journals, and other organizations

New Hope For Immunocompromised Individuals With Drug-resistant Fungal Infections

Date:
February 10, 2009
Source:
Whitehead Institute for Biomedical Research
Summary:
Even the most drug-resistant fungi can be eradicated in multiple in vitro and in vivo models using a lethal combination of an antifungal agent and inhibition of a specific heat shock protein (Hsp90). Such findings could point to a novel approach for the development of future antifungal therapies for patients with compromised immune systems. Immunocompromised individuals -- including HIV, chemotherapy, and organ transfer patients -- with drug-resistant fungal infections suffer mortality rates ranging from 50 to 90 percent.

The researchers found that when antifungals or Hsp90 inhibitors are used individually, they are ineffective; however, when paired they form a deadly duo. Not only did this work in a test tube, but it also worked to cure a lethal infection in an invertebrate model of fungal disease. On the left, are greater wax moth (Galleria mellonella) larvae that are light colored and healthy while on the right are those that were killed by a deadly fungus. Amazingly, the drug combination can rescue 100% of the larvae.
Credit: Copyright 2009 National Academy of Sciences, U.S.A.

Even the most drug-resistant fungi can be eradicated in multiple in vitro and in vivo models using a lethal combination of an antifungal agent and inhibition of the heat shock protein Hsp90, according to a new study by Whitehead Institute and University of Toronto researchers. The findings could enable development of novel antifungal therapies for patients with compromised immune systems.

Immunocompromised individuals--including HIV, chemotherapy, and organ transfer patients--with resistant fungal infections suffer mortality rates ranging from 50 to 90 percent.

"Being a pediatric oncologist, I have seen many unfortunate patients die from resistant fungal infections," says Luke Whitesell, a scientist in the lab of Whitehead Member Susan Lindquist. "It's incredibly frustrating to see a child with their cancer in remission being slowly eaten alive by a fungus like Aspergillus, and there's nothing you can do about it."

The development of effective antifungal drugs is limited by humans' close evolutionary relationship with fungi, and, in recent years, fungi's ever-evolving resistance to existing drugs. Former Lindquist postdoctoral researcher and lead author of this study, Leah Cowen, explains: "The drugs just don't wipe out the infection. So you wind up with a small population of fungi living in a host that is exposed to the drug for a long time, which favors evolution of drug resistance."

Previous studies suggested that Hsp90, which is found in both fungi and humans, plays a vital role in the evolution of drug resistance. In this most recent study, which appears in the February 24 issue of the Proceedings of the National Academy of Science (PNAS), Whitehead researchers tested Hsp90 inhibitors in combination with common antifungal drugs in an attempt to block the growth of Candida albicans and Aspergillus fumigatus, two of the most prevalent and lethal species that cause fungal infections in humans.

The researchers found that when antifungals or Hsp90 inhibitors are used individually, they are ineffective; however, when paired they form a deadly duo.

"When you combine the two, you reduce Hsp90 function enough that the fungi can no longer mount the crucial stress responses to antifungals required for survival," says Cowen. "So you cripple the fungus by severely compromising its stress responses."

According to Lindquist, "This is an entirely new strategy for making fungi susceptible to preexisting drugs and for preventing fungi from deploying the resistance mechanisms, which they have evolved against those compounds. It could make the difference between life and death."

Because Hsp90 is highly conserved, finding a compound to turn off Hsp90 in fungi, but not in humans, is a significant hurdle scientists must overcome. In addition, current Hsp90 inhibitors are toxic in mice with resistant fungal infections. To find promising Hsp90 inhibitors for antifungal therapy, Lindquist's lab has received a grant from the Molecular Libraries Probe Center Network (MLPCN) Program of the National Institutes of Health. The grant will allow researchers to screen large numbers of compounds in the search for potential fungus-selective Hsp90 inhibitors.

Still, even if the screen is successful, the battle between humans and fungi is not over.

"Eventually, like most drugs, Hsp90 inhibitors too, will become subject to resistance," suggests Lindquist, who is also a Howard Hughes Medical Institute investigator and professor of biology at MIT. "But in the meantime, these inhibitors will open a very large window of opportunity for individuals with resistant fungal infections."

This research was supported by Damon Runyon Cancer Research Foundation, a Genzyme Fellowship, the Burroughs Wellcome Fund, the G. Harold and Leila Y. Mathers Charitable Foundation, and a Canadian Institutes for Health Research Grant.

Susan Lindquist's primary affiliation is with Whitehead Institute for Biomedical Research, where her laboratory is located and all her research is conducted. She is also a Howard Hughes Medical Institute investigator and a professor of biology at Massachusetts Institute of Technology.


Story Source:

The above story is based on materials provided by Whitehead Institute for Biomedical Research. Note: Materials may be edited for content and length.


Journal Reference:

  1. Leah E. Cowen, Sheena D. Singh, Julia R. Kφhler, Cathy Collins, Aimee K. Zaas, Wiley A. Schell, Hamza Aziz, Eleftherios Mylonakis, John R. Perfect, Luke Whitesell, and Susan Lindquist. Harnessing Hsp90 function as a powerful, broadly effective therapeutic strategy for fungal infectious disease. Proceedings of the National Academy of Sciences, 2009; DOI: 10.1073/pnas.0813394106

Cite This Page:

Whitehead Institute for Biomedical Research. "New Hope For Immunocompromised Individuals With Drug-resistant Fungal Infections." ScienceDaily. ScienceDaily, 10 February 2009. <www.sciencedaily.com/releases/2009/02/090209205317.htm>.
Whitehead Institute for Biomedical Research. (2009, February 10). New Hope For Immunocompromised Individuals With Drug-resistant Fungal Infections. ScienceDaily. Retrieved September 30, 2014 from www.sciencedaily.com/releases/2009/02/090209205317.htm
Whitehead Institute for Biomedical Research. "New Hope For Immunocompromised Individuals With Drug-resistant Fungal Infections." ScienceDaily. www.sciencedaily.com/releases/2009/02/090209205317.htm (accessed September 30, 2014).

Share This



More Health & Medicine News

Tuesday, September 30, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

How 'Yes Means Yes' Defines Sexual Assault

How 'Yes Means Yes' Defines Sexual Assault

Newsy (Sep. 29, 2014) — Aimed at reducing sexual assaults on college campuses, California has adopted a new law changing the standard of consent for sexual activity. Video provided by Newsy
Powered by NewsLook.com
Scientists May Have Found An Early Sign Of Pancreatic Cancer

Scientists May Have Found An Early Sign Of Pancreatic Cancer

Newsy (Sep. 29, 2014) — Researchers looked at 1,500 blood samples and determined people who developed pancreatic cancer had more branched chain amino acids. Video provided by Newsy
Powered by NewsLook.com
Colo. Doctors See Cluster of Enterovirus Cases

Colo. Doctors See Cluster of Enterovirus Cases

AP (Sep. 29, 2014) — Doctors at the Children's Hospital of Colorado say they have treated over 4,000 children with serious respiratory illnesses since August. Nine of the patients have shown distinct neurological symptoms, including limb weakness. (Sept. 29) Video provided by AP
Powered by NewsLook.com
Dr.'s Unsure of Cause of Fast-Spreading Virus

Dr.'s Unsure of Cause of Fast-Spreading Virus

AP (Sep. 29, 2014) — Doctors at the Children's Hospital of Colorado say they have treated over 4,000 children with serious respiratory illnesses since August. Nine of the patients have shown distinct neurological symptoms, including limb weakness. (Sept. 29) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins